Clinical Trials

120 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT03797625 2025-07-23

Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas

Esophageal Squamous Cell Carcinoma

NCT06617936 2025-07-15

Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.

Phase 2 Recruiting

36 enrolled

Unresectable Non-small Cell Lung Cancer

NCT06965231 2025-05-11

FUMS-EDJS2024

Phase 2 Recruiting

58 enrolled

Dermatologic

Melanoma

NCT06301828 2024-03-08

Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors

16 enrolled

Gastrointestinal Neoplasms

NCT05203276 2023-06-22

Envafolimab Combined With Endostar in the First-line Treatment of Advanced NSCLC

40 enrolled

Lung Neoplasms

NCT05907512 2023-06-22

Endostar Plus Toripalimab as Adjuvant Therapy for Resectable Stage III-Oligometastatic Stage IV Cutaneous Melanoma

43 enrolled

Dermatologic

Melanoma

NCT05879796 2023-05-30

Envafolimab Combined With Endostar and Concurrent Chemoradiotherapy for Locally Advanced Primary Cervical Cancer

Not yet recruiting

Gynecologic

Uterine Cervical Neoplasms

NCT02350517 2023-02-16

Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal Cancer

Esophageal Squamous Cell Carcinoma

NCT05574998 2022-10-12

FTANLCNDG

100 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05529355 2022-09-07

Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer

45 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02749526 2022-07-29

Endostar Combined With MPFC Adjuvant Treatment of Esophageal Cancer Clinical Trial

Phase 2 Terminated

70 enrolled

Esophageal

NCT05298020 2022-03-28

Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer

20 enrolled

Advanced Pancreatic Cancer

NCT02237924 2022-02-14

Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Nasopharyngeal Carcinoma

120 enrolled

Nasopharyngeal Carcinoma

NCT05177237 2022-01-04

Endostar Combined With Corticosteroid for Treatment of Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

NCT04942301 2021-06-30

PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy

Phase 1 Unknown

24 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02636231 2021-02-03

Endostar for Locally Recurrent Nasopharyngeal Carcinoma

96 enrolled

Nasopharyngeal Carcinoma, Recurrence

NCT04613284 2020-11-03

RELIEF

Phase 4 Unknown

97 enrolled

Lung Neoplasms

NCT03989830 2020-10-23

SLICER

53 enrolled

Head and Neck Neoplasms

NCT02444949 2020-06-24

A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal Carcinoma

75 enrolled

Nasopharyngeal Neoplasms

NCT04274270 2020-03-19

SBRTLCES

Phase NA Unknown

60 enrolled

Lung Neoplasms, Radiation Injuries

NCT04303130 2020-03-10

Camrelizumab Combined With Endostar for First-line Treatment in Subjects With Advanced Squamous NSCLC

Carcinoma, Non-Small-Cell Lung

NCT03121833 2019-12-26

Endostar Combined With Chemotherapy for Stage Ⅳ Soft Tissue Sarcoma

Sarcoma

NCT04121975 2019-10-10

CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer

82 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT01907529 2019-08-09

TENDENCY

Phase 2/3 Unknown

300 enrolled

Breast

Breast Neoplasms

NCT03932266 2019-04-30

Endostar Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy for Locoregional Nasopharyngeal Carcinoma

73 enrolled

Nasopharyngeal Carcinoma

NCT03907098 2019-04-08

Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer

50 enrolled

Breast

Breast Neoplasms

NCT02902432 2019-01-31

A Trial of Endostar in Patients With Carcinoma of the Head and Neck

24 enrolled

Nasopharyngeal Neoplasms

NCT03706703 2018-10-17

Rh-Endostatin (Endostar®) Continuous Intravenous Infusion

50 enrolled

Lung Neoplasms

NCT03649945 2018-08-28

Endostatin Combined With Chemotherapy for Adjuvant Treatment of Esophageal Cancer

186 enrolled

Esophageal Neoplasms

NCT03614065 2018-08-03

Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC

50 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03588494 2018-07-17

Endostar in Combination With Chemoradiotherapy in Patient With Advanced Non-small Cell Lung Cancer

Phase 2/3 Unknown

318 enrolled

Quality of Life

NCT02590133 2017-12-22

A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC

328 enrolled

Nasopharyngeal Carcinoma

NCT03123445 2017-04-21

Endostar First-line Treatment of Advanced NSCLC

150 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02579564 2016-10-21

Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients

Phase 3 Unknown

134 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02907710 2016-09-20

Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 3 Unknown

300 enrolled

Nasopharyngeal Carcinoma

NCT02865304 2016-08-12

The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative MBC Patients

Phase 3 Unknown

80 enrolled

Breast

Breast Neoplasms

NCT02804646 2016-06-21

Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma

Phase 4 Unknown

100 enrolled

Adenocarcinoma of Lung

NCT02615106 2016-06-14

Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma

60 enrolled

CNS

Neuroblastoma

NCT02665702 2016-01-28

Endostar Combined With NVB and DDP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas

76 enrolled

Esophageal Squamous Cell Carcinoma

NCT01430013 2015-11-04

Trial of Endostar Combined With CHOPT for T Cell Lymphoma

Lymphoid

Lymphoma, T-Cell

NCT02513355 2015-08-04

Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research

Phase 4 Unknown

400 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02497118 2015-07-14

Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLC

Phase 4 Completed

Carcinoma, Non-Small-Cell Lung

NCT00842491 2015-05-19

Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer

45 enrolled

Advanced Gastric Cancer

NCT02375022 2015-03-24

Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations

10 enrolled

Lung Neoplasms

NCT02350361 2015-01-29

Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance.

Phase 2/3 Unknown

60 enrolled

Lung Neoplasms

NCT01002092 2014-09-03

A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma

160 enrolled

Sarcoma

Osteosarcoma

NCT01327235 2014-08-01

Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites

336 enrolled

Pleural Effusion, Malignant

NCT01612286 2014-02-19

Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma